🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Ovarii › New Jersey › Edison

Qorannoo klinikaalii Kansarii Ovarii Edison, NJ keessatti

Qorannoo 20 Kansarii Ovarii f Edison fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Namoota walitti qabaa jiraSadarkaa 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
  • Robert Wood Johnson University Hospital Somerset, Somerville · Miili 11 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05564377

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • START New Jersey, East Brunswick · Miili 6 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06270706

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Namoota walitti qabaa jiraSadarkaa 1
  • Research Site, New Brunswick · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT05877599

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Namoota walitti qabaa jiraSadarkaa 2
  • Rutgers Cancer Institute of New Jersey /ID# 274358, New Brunswick · Miili 3 fagaatti
Umuriin 18 fi ol · Dubartoota · Haaromfame 29-Ful-2026 · NCT06890338

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Namoota walitti qabaa jiraSadarkaa 2
  • Research Site, East Brunswick · Miili 6 fagaatti
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT05489211

A Study of Isoquercetin in People With Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07303894

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

Namoota walitti qabaa jiraSadarkaa 1/2
  • START New Jersey East Brunswick, East Brunswick · Miili 6 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06303505

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Astera Cancer Care, East Brunswick · Miili 6 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT05059444

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • START - New Jersey, East Brunswick · Miili 6 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT06293898

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Namoota walitti qabaa jiraSadarkaa 3
  • Rutgers Cancer Institute of New Jersey ( Site 0071), New Brunswick · Miili 3 fagaatti
Umuriin 18 fi ol · Dubartoota · Haaromfame 03-Ful-2026 · NCT06824467

Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • Start Njeb, East Brunswick · Miili 6 fagaatti
Umuriin 18 fi ol · Dubartoota · Haaromfame 01-Ful-2026 · NCT07736937

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Namoota walitti qabaa jiraSadarkaa 2/3
  • Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT07001748

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Namoota walitti qabaa jira
  • Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
  • Virtua Voorhees, Voorhees Township · Miili 5 fagaatti
  • Robert Wood Johnson University Hospital Somerset, Somerville · Miili 11 fagaatti
  • fi 1 dabalataa
Umuriin 35 hanga 50 · Dubartoota · Haaromfame 07-Hag-2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
  • Robert Wood Johnson University Hospital Somerset, Somerville · Miili 11 fagaatti
  • Summit Medical Group, Berkeley Heights · Miili 11 fagaatti
  • fi 1 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06580314

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

Namoota walitti qabaa jira
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · Miili 15 fagaatti
Umuriin 18 fi ol · Dubartoota · Haaromfame 01-Ado-2026 · NCT05429970

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

Namoota walitti qabaa jiraSadarkaa 2
  • Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Elb-2026 · NCT06290193

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Gur-2026 · NCT06623396

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Namoota walitti qabaa jiraSadarkaa 2
  • Rutgers Cancer Institute, New Brunswick · Miili 3 fagaatti
Umuriin 18 fi ol · Dubartoota · Haaromfame 23-Mud-2025 · NCT06690775

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, New Brunswick · Miili 3 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Exelixis Clinical Site #9, New Brunswick · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Ful-2025 · NCT05932862

Qorannoo Kansarii Ovarii magaalota biroo keessatti

Qorannoo biroo Edison keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.